SCHEMBL31137369

SCHEMBL31137369

FC1(F)CC(NCc2ccc(C(F)(F)F)cn2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HDAC1 Q13547 4/20 0.39
▸ HDAC8 Q9BY41 4/20 0.39
▸ HDAC6 Q9UBN7 4/20 0.39
▸ SCN7A Q01118 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ SCN10A Q9Y5Y9 1/20 0.39
▸ PDE2A O00408 1/20 0.37
▸ HCRTR1 O43613 1/20 0.36
▸ HCRTR2 O43614 1/20 0.36
▸ DAO P14920 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ TRPV3 Q8NET8 2/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23774860 0.87 KDM1A (0.48) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL29456936 0.85 KDM1A (0.59) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL19650813 0.85 KDM1A (0.59) KDM1AMAOAMAOBNPC1RAB9A
Hydrochloric Acid SCHEMBL30615191 0.84 KDM1A (0.58) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL25227588 0.83 KDM1A (0.55) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL23545585 0.82 KDM1A (0.56) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL30471935 0.82 KDM1A (0.56) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL25374816 0.80 KDM1A (0.54) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL24468271 0.79 KDM1A (0.53) KDM1AMAOAMAOBNPC1RAB9A
SCHEMBL23774961 0.76 KDM1A (0.50) KDM1AMAOAMAOBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388585-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-12-25 — — US disclosed
US-12448388-B2 PRMT5 inhibitors and uses thereof GILEAD SCIENCES, INC. (US) 2025-10-21 — — US disclosed
US-20240376110-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. 2024-11-14 — — US disclosed
WO-2024220917-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2024-10-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388585-A1 PRMT5 INHIBITORS AND USES THEREOF PRMT1, PRMT5, PRMT6 KDM1A 113/4885MAOA 4148/4885MAOB 3747/4885
US-20240376110-A1 PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT9 KDM1A 113/4885MAOA 3667/4885MAOB 3146/4885
US-12448388-B2 PRMT5 inhibitors and uses thereof PRMT5, PRMT1, PRMT9 KDM1A 113/4885MAOA 3667/4885MAOB 3146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback